Chinese Journal of Dermatology ›› 2022, Vol. 55 ›› Issue (6): 471-479.doi: 10.35541/cjd.20210434

• Expert Commentary • Previous Articles     Next Articles

Cyclosporine in the treatment of immune-related skin diseases: an expert proposal

Committee on Autoimmune Diseases, China Dermatologist Association   

  1. Committee on Autoimmune Diseases, China Dermatologist Association
  • Received:2021-06-08 Revised:2022-03-30 Online:2022-06-15 Published:2022-06-02
  • Contact: Guo Qing E-mail:guoqingzsy@163.com

Abstract: 【Abstract】 Cyclosporine, a kind of calcineurin inhibitor, is a potent non-cytotoxic immunosuppressant. It mainly acts on T lymphocytes and exerts an immunosuppressive effect by inhibiting T lymphocyte proliferation and cytokine transcription. Cyclosporine is commonly used in the treatment of psoriasis and atopic dermatitis in dermatology, and has also been reported for the treatment of systemic lupus erythematosus, dermatomyositis, vasculitis and other diseases. Based on Chinese and international literature (mainly including randomized controlled clinical trials, expert consensus or proposals)on cyclosporine in the treatment of immune-related skin diseases, relevant Chinese experts developed a proposal on cyclosporine in the treatment of immune-related skin diseases after repeated discussions.

Key words: Cyclosporine, Autoimmune diseases, Psoriasis, Lupus erythematosus, systemic, Dermatomyositis, Scleroderma, localized, Skin diseases, vesiculobullous